 |
Kidney Cancer News - Special Coverage - Cancer News RSS Feeds from Brightsurf Science News
Special Coverage - Cancer :: Kidney Cancer
Kidney Cancer News Stories, Current Kidney Cancer News Events, Discoveries and Articleshttp://www.brightsurf.com/rss.news.xml?search=Kidney_Cancer
Kidney Cancer News Stories
Current Kidney Cancer News Events, Discoveries and Articles
Drug fends off kidney cancer progression
New data from an international, multicenter Phase III clinical trial has found that the experimental targeted therapy everolimus (RAD001) significantly delays cancer progression in patients with metastatic kidney cancer whose disease had worsened on other treatments. (2008-05-19)
Majority of kidney cancers diagnosed at earliest stage
Patients in the United States today are now much more likely to be diagnosed with smaller tumors, in the earliest, most treatable stage of kidney cancer than a decade ago, leading to a slightly higher survival rate, according to the results of a national study led by a UC San Diego Medical Center researcher. (2008-05-19)
Overweight and obesity cause 6,000 cancers a year in UK women
The study shows that overweight and obese women in the UK are at a higher risk of developing and dying from cancer. In fact, the researchers estimate that 5% of all cancers (about 6,000 annually) are attributable to being overweight or obese. (2007-11-07)
Study shows blood markers can help choose best dose for antiangiogenic drugs
Scientists at Sunnybrook have new information that may help to improve the use of anti-cancer drugs designed to block the growth of new blood vessels in tumors, a process called angiogenesis that is critical to tumor growth. (2007-10-26)
Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
Surgeons specializing in laparoscopic procedures at UT Southwestern Medical Center have successfully removed a patient's kidney by performing a unique nephrectomy entirely through the belly button. (2007-08-24)
First biomarker discovered that predicts prostate cancer outcome
Mayo Clinic researchers have identified the first immune molecule that appears to play a role in prostate cancer development and in predicting cancer recurrence and progression after surgery. (2007-08-15)
FSU chemists using light-activated molecules to kill cancer cells
A key challenge facing doctors as they treat patients suffering from cancer or other diseases resulting from genetic mutations is that the drugs at their disposal often don't discriminate between healthy cells and dangerous ones -- think of the brute-force approach of chemotherapy, for instance. (2007-08-09)
Radiofrequency ablation highly effective in treating kidney tumors
A relatively new, minimally invasive treatment was 93 percent successful in eradicating malignant kidney tumors, according to a recent study conducted by researchers from Wake Forest University Baptist Medical Center in Winston-Salem, NC. (2007-08-06)
Researchers shed light on mechanism of action used by anti-cancer drug
Virginia Commonwealth University Massey Cancer Center researchers have uncovered a new mechanism of action of the anti-cancer drug sorafenib, which could stimulate the development of novel regimens in which it is combined with other molecularly targeted agents for patients with blood cancers and solid tumors. (2007-06-12)
Glowing dye improves cancer removal in kidney
A new way to provide clear images of cancerous tumors in the kidney during surgery promises to help physicians preserve as much kidney function as possible while still removing all the malignant tissue - a significant advance as doctors discover that saving as much healthy kidney tissue as possible is crucial for the future health of cancer patients. (2007-06-06)
Current Kidney Cancer News Events, Discoveries and Articles
Drug fends off kidney cancer progression
New data from an international, multicenter Phase III clinical trial has found that the experimental targeted therapy everolimus (RAD001) significantly delays cancer progression in patients with metastatic kidney cancer whose disease had worsened on other treatments. (2008-05-19)
Majority of kidney cancers diagnosed at earliest stage
Patients in the United States today are now much more likely to be diagnosed with smaller tumors, in the earliest, most treatable stage of kidney cancer than a decade ago, leading to a slightly higher survival rate, according to the results of a national study led by a UC San Diego Medical Center researcher. (2008-05-19)
Overweight and obesity cause 6,000 cancers a year in UK women
The study shows that overweight and obese women in the UK are at a higher risk of developing and dying from cancer. In fact, the researchers estimate that 5% of all cancers (about 6,000 annually) are attributable to being overweight or obese. (2007-11-07)
Study shows blood markers can help choose best dose for antiangiogenic drugs
Scientists at Sunnybrook have new information that may help to improve the use of anti-cancer drugs designed to block the growth of new blood vessels in tumors, a process called angiogenesis that is critical to tumor growth. (2007-10-26)
Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
Surgeons specializing in laparoscopic procedures at UT Southwestern Medical Center have successfully removed a patient's kidney by performing a unique nephrectomy entirely through the belly button. (2007-08-24)
First biomarker discovered that predicts prostate cancer outcome
Mayo Clinic researchers have identified the first immune molecule that appears to play a role in prostate cancer development and in predicting cancer recurrence and progression after surgery. (2007-08-15)
FSU chemists using light-activated molecules to kill cancer cells
A key challenge facing doctors as they treat patients suffering from cancer or other diseases resulting from genetic mutations is that the drugs at their disposal often don't discriminate between healthy cells and dangerous ones -- think of the brute-force approach of chemotherapy, for instance. (2007-08-09)
Radiofrequency ablation highly effective in treating kidney tumors
A relatively new, minimally invasive treatment was 93 percent successful in eradicating malignant kidney tumors, according to a recent study conducted by researchers from Wake Forest University Baptist Medical Center in Winston-Salem, NC. (2007-08-06)
Researchers shed light on mechanism of action used by anti-cancer drug
Virginia Commonwealth University Massey Cancer Center researchers have uncovered a new mechanism of action of the anti-cancer drug sorafenib, which could stimulate the development of novel regimens in which it is combined with other molecularly targeted agents for patients with blood cancers and solid tumors. (2007-06-12)
Glowing dye improves cancer removal in kidney
A new way to provide clear images of cancerous tumors in the kidney during surgery promises to help physicians preserve as much kidney function as possible while still removing all the malignant tissue - a significant advance as doctors discover that saving as much healthy kidney tissue as possible is crucial for the future health of cancer patients. (2007-06-06)
| © 2008 BrightSurf.com |